Our lab creates in vitro models of human neurodegenerative diseases by converting patients’ skin fibroblasts into disease-affected neural cells. This enables us to screen thousands of drug-like compounds in search of potential therapeutics that slow or stop the degeneration of these cells in petri dishes — and eventually in patients.
- Verge Genomics announces a multi-institution collaboration with Columbia University, MGH, USC and the University of Michigan to advance ALS research September 22, 2017
- Carina Seah featured in undergraduate research video August 29, 2017
- Kim Staats looks for the pattern in sporadic cases of ALS June 12, 2017